<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2020-01-02">
  <drugbank-id primary="true">DB11239</drugbank-id>
  <name>Aluminum sulfate</name>
  <description>Aluminum (Al), also spelled aluminum, chemical element, a lightweight, silvery-white metal of main Group 13 (IIIa, or boron group) of the periodic table [L2148].&#13;
&#13;
It is a chemical agent used in water purification, the pH regulation of garden soil, and other commercial or industrial applications. Medically, it is primarily used as a coagulating agent in minor cuts and abrasions as well as deodorant [L2144].&#13;
&#13;
Aluminum (Al) is ubiquitous and represents the third most common element in the Earth’s crust. It most commonly exists in a combined state with various other elements. Al is found in materials used in the pharmaceutical industry, and in manufactured foodstuffs, cosmetics, and tap water. By overcoming the body barriers, Al may infiltrate into the blood and lead to toxic effects in liver, bone and the central nervous system [L2145].</description>
  <cas-number>10043-01-3</cas-number>
  <unii>I7T908772F</unii>
  <average-mass>342.151</average-mass>
  <monoisotopic-mass>341.818264416</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32455</ref-id>
        <pubmed-id>10437134</pubmed-id>
        <citation>Wu YH, Zhou ZM, Xiong YL, Wang YL, Sun JH, Liao HB, Luo XD: Effects of aluminum potassium sulfate on learning, memory, and cholinergic system in mice. Zhongguo Yao Li Xue Bao. 1998 Nov;19(6):509-12.</citation>
      </article>
      <article>
        <ref-id>A32456</ref-id>
        <pubmed-id>25314162</pubmed-id>
        <citation>Cabus N, Oguz EO, Tufan AC, Adiguzel E: A histological study of toxic effects of aluminium sulfate on rat hippocampus. Biotech Histochem. 2015 Feb;90(2):132-9. doi: 10.3109/10520295.2014.965277. Epub  2014 Oct 14.</citation>
      </article>
      <article>
        <ref-id>A32460</ref-id>
        <pubmed-id>10999429</pubmed-id>
        <citation>Cunat L, Lanhers MC, Joyeux M, Burnel D: Bioavailability and intestinal absorption of aluminum in rats: effects of aluminum compounds and some dietary constituents. Biol Trace Elem Res. 2000 Jul;76(1):31-55. doi: 10.1385/BTER:76:1:31.</citation>
      </article>
      <article>
        <ref-id>A32464</ref-id>
        <pubmed-id>16045991</pubmed-id>
        <citation>Darbre PD: Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005 Sep;99(9):1912-9. doi: 10.1016/j.jinorgbio.2005.06.001.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L2144</ref-id>
        <title>Aluminum sulfate PubChem</title>
        <url>https://pubchem.ncbi.nlm.nih.gov/compound/3080712</url>
      </link>
      <link>
        <ref-id>L2145</ref-id>
        <title>Aluminium sulphate exposure increases oxidative stress and suppresses brain development in Ross broiler chicks</title>
        <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560745/</url>
      </link>
      <link>
        <ref-id>L2146</ref-id>
        <title>Aluminum Sulfate</title>
        <url>https://www.drugs.com/ingredient/aluminum-sulfate.html</url>
      </link>
      <link>
        <ref-id>L2147</ref-id>
        <title>Aluminum Sulfate, Brittanica online</title>
        <url>https://www.britannica.com/science/aluminum-sulfate</url>
      </link>
      <link>
        <ref-id>L2148</ref-id>
        <title>Aluminum Sulfate Excipient</title>
        <url>https://www.drugs.com/inactive/aluminum-sulfate-596.html</url>
      </link>
      <link>
        <ref-id>L2149</ref-id>
        <title>Aluminum in Drinking Water</title>
        <url>http://apps.who.int/iris/bitstream/handle/10665/75362/WHO_SDE_WSH_03.04_53_eng.pdf;jsessionid=D408B68ACD76B131D7F51835F1F1DD38?sequence=1</url>
      </link>
      <link>
        <ref-id>L2150</ref-id>
        <title>HIS STYPTIC PENCIL- aluminum sulfate stick </title>
        <url>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50c679f9-b082-4a3b-9d26-661300e95271&amp;audience=consumer#</url>
      </link>
      <link>
        <ref-id>L2152</ref-id>
        <title>EMA document</title>
        <url>http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010018.pdf</url>
      </link>
      <link>
        <ref-id>L2154</ref-id>
        <title>ToxNet, Aluminum sulfate</title>
        <url>https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5067</url>
      </link>
      <link>
        <ref-id>L2155</ref-id>
        <title>InChem, Aluminum Sulfate</title>
        <url>http://www.inchem.org/documents/ukpids/ukpids/ukpid34.htm</url>
      </link>
      <link>
        <ref-id>L2156</ref-id>
        <title> PRIORITY SUBSTANCES LIST ASSESSMENT REPORT</title>
        <url>https://www.ec.gc.ca/lcpe-cepa/documents/substances/sa-as/assessment_rpt-eng.pdf</url>
      </link>
      <link>
        <ref-id>L2157</ref-id>
        <title>Aluminium Toxicokinetics: An Updated MiniReview</title>
        <url>https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0773.2001.880401.x</url>
      </link>
      <link>
        <ref-id>L2158</ref-id>
        <title>Aluminum Sulfate Overview</title>
        <url>https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/aluminium-sulfate</url>
      </link>
      <link>
        <ref-id>L2159</ref-id>
        <title>Hazardous Materials Sheet, NJ</title>
        <url>http://www.nj.gov/health/eoh/rtkweb/documents/fs/0068.pdf</url>
      </link>
      <link>
        <ref-id>L2160</ref-id>
        <title>Formulation and evaluation of potash alum as deodorant lotion and after shaving astringent as cream and gel</title>
        <url>https://www.banglajol.info/index.php/ICPJ/article/viewFile/17512/12288</url>
      </link>
      <link>
        <ref-id>L2161</ref-id>
        <title>Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study</title>
        <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514401/</url>
      </link>
      <link>
        <ref-id>L2164</ref-id>
        <title>ASSURED- aluminum sulfate powder </title>
        <url>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad067b04-ff57-44ab-a6cb-f524f8294989&amp;audience=consumer</url>
      </link>
      <link>
        <ref-id>L2165</ref-id>
        <title>Antiperspirants/Deodorants and Breast Cancer</title>
        <url>https://www.cancer.gov/about-cancer/causes-prevention/risk/myths/antiperspirants-fact-sheet</url>
      </link>
      <link>
        <ref-id>L2167</ref-id>
        <title>Underarm antiperspirants/deodorants and breast cancer</title>
        <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797685/</url>
      </link>
      <link>
        <ref-id>L2168</ref-id>
        <title>BREAST CANCER AND DEODORANTS/ ANTIPERSPIRANTS: A SYSTEMATIC REVIEW</title>
        <url>https://pdfs.semanticscholar.org/2877/4ce8ef9459eac3d0fb8ef8db755aa75dc492.pdf</url>
      </link>
      <link>
        <ref-id>L2169</ref-id>
        <title>Influence of Lifestyle Factors on Breast Cancer Risk</title>
        <url>https://www.karger.com/Article/Abstract/369571</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Solutions containing 5 to 10% aluminum sulfate have been used as local applications to ulcers and to arrest foul discharges from mucous surfaces. Aluminum sulfate is also used in the preparation of aluminum acetate ear drops [L2149].  It is often purchased over the counter and is available in solid stick or powder form for minor cuts and abrasions after shaving [L2157], [L2164]. Aluminum sulfate is also used as an adjuvant in vaccines [L2158].</indication>
  <pharmacodynamics>Aluminum sulfate may be used as a deodorant, as well as an astringent [L2160]. Aluminum sulfate is also known as an astringent. Astringents are substances that cause contraction or shrinkage of tissues and that dry up secretion [L2160].&#13;
&#13;
Used as a post-shaving treatment, it can eliminate bleeding from superficial wounds [L2157], [L2164].   &#13;
&#13;
It has also shown in vitro anti-microbial activity [L2160].&#13;
</pharmacodynamics>
  <mechanism-of-action>When used as a deodorant, the volume of sweat produced is reduced by narrowing sweat ducts. The inhibition of body odor causing bacteria is another important strategy for deodorization [L2160]. &#13;
&#13;
By inhibiting or deactivating odor-producing bacteria, there is little to none metabolism of sweat components thus decreasing the occurrence of body odor [L2160]. &#13;
&#13;
Recent studies suggest that the active binding of alum to the membranes of dendritic cells (DCs) result in alteration of lipid membranes structures as a key process in alum's adjuvant effect in vaccines. As new adjuvants are being developed, alum may remain as an ingredient of adjuvant combinations, or it may eventually be supplemented by other agents that more effectively provide depot and local inflammatory responses to accentuate host immune responses [L2158].</mechanism-of-action>
  <toxicity>&#13;
Aluminum Sulfate, Hydrated (ACS &amp; FCC): ORAL (LD50):&#13;
 **Acute:** &gt;9000 mg/kg in the ouse [MSDS]. &gt;9000 mg/kg in the rat [MSDS].&#13;
&#13;
&#13;
**Acute Toxicity** &#13;
&#13;
There is little indication that aluminum is acutely toxic by oral exposure despite it is widely found in foods, drinking water, and many antacid preparations [L2149]. In 1988, a population of about 20 000 citizens of Camelford, England, was exposed to increased levels of aluminum for 5 days. The aluminum was accidentally ingested by the population from a water supply facility using aluminum sulfate for water treatment [L2149].&#13;
&#13;
Some adverse effects observed were nausea, vomiting, diarrhea, mouth ulcers, skin ulcers, skin rashes, and arthritis-type pain were observed. It was concluded in one study that the adverse effects of aluminum sulfate were primarily mild and transient. No long-lasting effects on health could be attributed to the exposures from aluminum in the drinking water during this period [L2149].&#13;
&#13;
**Chronic Toxicity**&#13;
&#13;
In humans, excess exposure to aluminum via dialysis water (aluminum sulfate) is a known etiological factor in several pathological conditions in patients treated with hemodialysis. Clinical symptoms and signs of aluminum toxicity include hypercalcemia, anemia, vitamin D refractory osteodystrophy, and a dialysis encephalopathy. Bone pain, pathological fractures, and proximal myopathy may occur. Aluminum has also been suggested as an etiology of several neurodegenerative diseases such as Alzheimer senile and pre-senile dementia, as well amyotrophic sclerosis. Despite this, the most recent investigations have failed to confirm this hypothesis. A study in man has verified a number of possible deleterious interactions of aluminum salts with phosphorous metabolism, especially in long-term ingestion of aluminum-containing antacids [L2152].&#13;
&#13;
It has been suggested that aluminum exposure is a risk factor for the development or acceleration of onset of Alzheimer disease (AD) in humans. The world health organization has completed a meta-analysis of 20 epidemiological studies done to test the hypothesis that aluminum in drinking-water is a risk factor for Alzheimer disease. Six studies on populations in Norway were considered of sufficiently high quality to meet the general criteria for exposure and outcome assessment and the adjustment for at least some confounding variables [L2149].&#13;
&#13;
 Of six studies that examined the relationship between aluminum in drinking- water and dementia, three found a positive relationship, but three did not. However, each of the studies had significant deficiencies in the study design (e.g. ecological exposure assessment; failure to consider aluminum exposure from all sources and to control for important confounders, such as education, socioeconomic status, and family history; the use of surrogate outcome measures for AD; and selection bias) [L2149]. &#13;
&#13;
In general, the relative risks determined were less than 2, with large confidence intervals, when the total aluminum concentration in drinking-water was 0.1 mg/L or higher.  Due to the pathogenesis of AD and knowledge obtained from studies,  it was concluded that the present epidemiological evidence does not support a causal association between AD and aluminum in drinking-water  [L2149].&#13;
&#13;
In addition to the epidemiological studies that examined the relationship between AD and aluminum in drinking-water, two studies studied cognitive dysfunction in elderly populations in relation to the levels of aluminum in drinking water. The results proved conflicting. A study of 800 male subjects, age 80-89, drinking water containing aluminum concentrations up to 98 μg/L found no relationship. The second study used “any evidence of mental impairment” as an outcome measure and found a relative risk of 1.72 at aluminum drinking-water concentrations above 85 μg/L in 250 males. Such data are insufficient to show that aluminum is a cause of cognitive impairment in the elderly [L2149].&#13;
&#13;
**Note on possible risk of breast cancer**&#13;
&#13;
Widespread concern has been raised regarding the exposure to aluminum in deodorant/antiperspirant products, with inconclusive results [L2165], [L2167], [L2168], [L2169]. Results from a more recent case-control study suggest an association between underarm cosmetic use and aluminum concentration in breast tissue and breast cancer. The observed association of underarm cosmetic use with breast cancer was, however, limited to women who report using the products multiple times a day before age of 30 [A32464].</toxicity>
  <metabolism/>
  <absorption>The degree of aluminum absorption depends on a number of factors, such as the aluminum salt ingested, pH (for aluminum speciation and solubility), bioavailability, as well as dietary conditions [L2149].&#13;
&#13;
 These facts should be taken into consideration during tissue dosimetry and response assessment to aluminum sulfate. It can be concluded that the use of currently available animal studies to develop a guideline value is inappropriate at this time  due to the above specific toxicokinetic/dynamic factors that may affect results [L2149].</absorption>
  <half-life>Numerous studies have actually shown that the rate of aluminum clearance in the blood decreases with time following aluminum ingestion, and therefore a single elimination half-life (t1⁄2) cannot depict the whole-body elimination of aluminum  [L2156].</half-life>
  <protein-binding/>
  <route-of-elimination>Aluminum is excreted predominantly via the kidneys and therefore may accumulate in patients with renal failure [L2155]. About 2% is excreted in bile  [L2157].</route-of-elimination>
  <volume-of-distribution>Aluminium which is absorbed is located primarily in the heart, spleen, and bone [L2152].</volume-of-distribution>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as post-transition metal sulfates. These are inorganic compounds in which the largest oxoanion is sulfate, and in which the heaviest atom not in an oxoanion is a post-transition metal.</description>
    <direct-parent>Post-transition metal sulfates</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Post-transition metal oxoanionic compounds</class>
    <subclass>Post-transition metal sulfates</subclass>
    <alternative-parent>Inorganic oxides</alternative-parent>
    <alternative-parent>Inorganic salts</alternative-parent>
    <alternative-parent>Post-transition metal salts</alternative-parent>
    <substituent>Inorganic oxide</substituent>
    <substituent>Inorganic post-transition metal salt</substituent>
    <substituent>Inorganic salt</substituent>
    <substituent>Post-transition metal sulfate</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT002664</drugbank-id>
      <name>Aluminum sulfate hydrate</name>
      <unii>34S289N54E</unii>
      <cas-number>17927-65-0</cas-number>
      <inchikey>BUACSMWVFUNQET-UHFFFAOYSA-H</inchikey>
      <average-mass>360.15</average-mass>
      <monoisotopic-mass>359.8288306</monoisotopic-mass>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT002778</drugbank-id>
      <name>Aluminum sulfate tetradecahydrate</name>
      <unii>E3UT66504P</unii>
      <cas-number>16828-12-9</cas-number>
      <inchikey>GUNGYIXTFIIJDK-UHFFFAOYSA-H</inchikey>
      <average-mass>594.34</average-mass>
      <monoisotopic-mass>593.9661715</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">Aluminium sulfate</synonym>
    <synonym language="english" coder="">Aluminium sulfate anhydrous</synonym>
    <synonym language="english" coder="">Aluminum sulfate anhydrous</synonym>
    <synonym language="english" coder="">Aluminum sulphate anhydrous</synonym>
    <synonym language="english" coder="">Dialuminum sulfate</synonym>
    <synonym language="english" coder="">Dialuminum trisulfate</synonym>
  </synonyms>
  <products>
    <product>
      <name>Aluminum Acetate Astringent</name>
      <labeller>Epic Pharma, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>42806-106</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on>2013-04-30</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aluminum Acetate Astringent</name>
      <labeller>Tagi Pharma Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code>51224-153</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-06-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Assured</name>
      <labeller>Greenbrier International, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>33992-0828</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-04-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength>56 g/100g</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Astringent</name>
      <labeller>TAGI Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51224-162</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Domeboro</name>
      <labeller>MOBERG PHARMA NORTH AMERICA LLC</labeller>
      <ndc-id/>
      <ndc-product-code>16864-240</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-06-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingi-Aid MAX Z-Twist 00</name>
      <labeller>Gingi-Pak a Division of the Belport</labeller>
      <ndc-id/>
      <ndc-product-code>10129-059</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>54 mg/1</strength>
      <route>Dental; Oral; Periodontal</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingi-Aid MAX Z-Twist 1</name>
      <labeller>Gingi-Pak a Division of the Belport</labeller>
      <ndc-id/>
      <ndc-product-code>10129-060</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>54 mg/1</strength>
      <route>Dental; Oral; Periodontal</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingi-Aid MAX Z-Twist 2</name>
      <labeller>Gingi-Pak a Division of the Belport</labeller>
      <ndc-id/>
      <ndc-product-code>10129-061</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-01-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>54 mg/1</strength>
      <route>Dental; Oral; Periodontal</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gingi-Aid MAX Z-Twist 3</name>
      <labeller>Gingi-Pak a Division of the Belport</labeller>
      <ndc-id/>
      <ndc-product-code>10129-062</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-07-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>54 mg/1</strength>
      <route>Dental; Oral; Periodontal</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HIS Styptic Pencil</name>
      <labeller>Pacific World Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>60193-501</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Stick</dosage-form>
      <strength>5.6 g/10g</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>KutKit</name>
      <labeller>Majestic Drug Co., INC.</labeller>
      <ndc-id/>
      <ndc-product-code>10705-300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Swab</dosage-form>
      <strength>0.05 g/1</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>KutKit</name>
      <labeller>Centrix, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60640-4018</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Swab</dosage-form>
      <strength>0.05 g/1</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nick Relief</name>
      <labeller>220 Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>57367-007</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-11-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Stick</dosage-form>
      <strength>46 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pascord 7 0.48mg/2.54cm</name>
      <labeller>Pascal International Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01959824</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-23</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rastringent II 250mg/ml</name>
      <labeller>Pascal International Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00574201</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-23</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Shaving Factory Disposable Styptic Pencil</name>
      <labeller>Derby International Llc</labeller>
      <ndc-id/>
      <ndc-product-code>76499-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Stick</dosage-form>
      <strength>9 mL/10mL</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sil Trax As No 10</name>
      <labeller>Pascal International Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00550396</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-25</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sil Trax As No 8</name>
      <labeller>Pascal International Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00519944</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-25</ended-marketing-on>
      <dosage-form>Packing</dosage-form>
      <strength/>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stingose Asp 373mg/ml</name>
      <labeller>Kinsmor Pharmaceuticals Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02018551</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2000-06-16</ended-marketing-on>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stingose Gel 20%</name>
      <labeller>Kinsmor Pharmaceuticals Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02040999</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-02</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Styptic Pencil Stick 42.0%</name>
      <labeller>Conglom, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00763675</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-06-01</started-marketing-on>
      <ended-marketing-on>2005-02-11</ended-marketing-on>
      <dosage-form>Stick</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Styptocaine</name>
      <labeller>Pedinol Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0884-1910</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-14</started-marketing-on>
      <ended-marketing-on>2013-11-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>46 g/100mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Trim Men Styptic Pencil</name>
      <labeller>Pacific World Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>60193-500</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Stick</dosage-form>
      <strength>5.6 g/10g</strength>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Nick Relief</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Shaving Factory Disposable Styptic Pencil</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Aluminum Acetate Astringent</name>
      <ingredients>Aluminum sulfate + Calcium acetate</ingredients>
    </mixture>
    <mixture>
      <name>Styptocaine</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Trim Men Styptic Pencil</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>HIS Styptic Pencil</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Assured</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Gingi-Aid MAX Z-Twist 1</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Gingi-Aid MAX Z-Twist 00</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Gingi-Aid MAX Z-Twist 3</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Gingi-Aid MAX Z-Twist 2</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Aluminum Acetate Astringent</name>
      <ingredients>Aluminum sulfate + Calcium acetate</ingredients>
    </mixture>
    <mixture>
      <name>Astringent</name>
      <ingredients>Aluminum sulfate + Calcium acetate</ingredients>
    </mixture>
    <mixture>
      <name>Domeboro</name>
      <ingredients>Aluminum sulfate + Calcium acetate</ingredients>
    </mixture>
    <mixture>
      <name>KutKit</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>KutKit</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Pascord 7 0.48mg/2.54cm</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Stingose Gel 20%</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Stingose Asp 373mg/ml</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Styptic Pencil Stick 42.0%</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Sil Trax As No 8</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Sil Trax As No 10</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Rastringent II 250mg/ml</name>
      <ingredients>Aluminum sulfate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Adjuvants, Immunologic</category>
      <mesh-id>D000276</mesh-id>
    </category>
    <category>
      <category>Aluminium Compounds</category>
      <mesh-id>D017607</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Immunologic Factors</category>
      <mesh-id>D007155</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Metal cations</category>
      <mesh-id>D002412</mesh-id>
    </category>
    <category>
      <category>Metal divalent cations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Sulfates</category>
      <mesh-id>D013431</mesh-id>
    </category>
    <category>
      <category>Sulfur Acids</category>
      <mesh-id>D013456</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Sulfuric Acids</category>
      <mesh-id>D013464</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Powder, for solution</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength>56 g/100g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Dental; Oral; Periodontal</route>
      <strength>54 mg/1</strength>
    </dosage>
    <dosage>
      <form>Swab</form>
      <route>Topical</route>
      <strength>0.05 g/1</strength>
    </dosage>
    <dosage>
      <form>Stick</form>
      <route>Topical</route>
      <strength>46 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Packing</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Dental</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Stick</form>
      <route>Topical</route>
      <strength>9 mL/10mL</strength>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Stick</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Topical</route>
      <strength>46 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Stick</form>
      <route>Topical</route>
      <strength>5.6 g/10g</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11239.pdf?1523291127</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB06210</drugbank-id>
      <name>Eltrombopag</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06817</drugbank-id>
      <name>Raltegravir</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08930</drugbank-id>
      <name>Dolutegravir</name>
      <description>The serum concentration of Dolutegravir can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01218</drugbank-id>
      <name>Halofantrine</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01586</drugbank-id>
      <name>Ursodeoxycholic acid</name>
      <description>The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02123</drugbank-id>
      <name>Glycochenodeoxycholic Acid</name>
      <description>The serum concentration of Glycochenodeoxycholic Acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02659</drugbank-id>
      <name>Cholic Acid</name>
      <description>The serum concentration of Cholic Acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02691</drugbank-id>
      <name>Glycocholic acid</name>
      <description>The serum concentration of Glycocholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03619</drugbank-id>
      <name>Deoxycholic acid</name>
      <description>The serum concentration of Deoxycholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04348</drugbank-id>
      <name>Taurocholic acid</name>
      <description>The serum concentration of Taurocholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05990</drugbank-id>
      <name>Obeticholic acid</name>
      <description>The serum concentration of Obeticholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06777</drugbank-id>
      <name>Chenodeoxycholic acid</name>
      <description>The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08833</drugbank-id>
      <name>Taurochenodeoxycholic acid</name>
      <description>The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08834</drugbank-id>
      <name>Tauroursodeoxycholic acid</name>
      <description>The serum concentration of Tauroursodeoxycholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08857</drugbank-id>
      <name>Bamet-UD2</name>
      <description>The serum concentration of Bamet-UD2 can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08858</drugbank-id>
      <name>cis-Diamminechlorocholylglycinateplatinum(II)</name>
      <description>The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11622</drugbank-id>
      <name>Dehydrocholic acid</name>
      <description>The serum concentration of Dehydrocholic acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11789</drugbank-id>
      <name>Hyodeoxycholic Acid</name>
      <description>The serum concentration of Hyodeoxycholic Acid can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11860</drugbank-id>
      <name>Aramchol</name>
      <description>The serum concentration of Aramchol can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14016</drugbank-id>
      <name>Ox bile extract</name>
      <description>The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09139</drugbank-id>
      <name>Technetium Tc-99m oxidronate</name>
      <description>The serum concentration of Technetium Tc-99m oxidronate can be increased when it is combined with Aluminum sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Phenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00532</drugbank-id>
      <name>Mephenytoin</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Mephenytoin resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00849</drugbank-id>
      <name>Methylphenobarbital</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Methylphenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Phenobarbital resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01609</drugbank-id>
      <name>Deferasirox</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Deferasirox resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01071</drugbank-id>
      <name>Mequitazine</name>
      <description>Aluminum sulfate can cause a decrease in the absorption of Mequitazine resulting in a reduced serum concentration and potentially a decrease in efficacy.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.84</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>dialuminium(3+) ion trisulfate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>dialuminium(3+) ion trisulfate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>342.151</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>341.818264416</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>Al2O12S3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/2Al.3H2O4S/c;;3*1-5(2,3)4/h;;3*(H2,1,2,3,4)/q2*+3;;;/p-6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>DIZPMCHEQGEION-UHFFFAOYSA-H</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>80.26</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>11.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>5.81</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value> 86.9 g/ 100 ml</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>700</value>
      <source>http://www.nj.gov/health/eoh/rtkweb/documents/fs/0068.pdf</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>1600</value>
      <source>http://www.nj.gov/health/eoh/rtkweb/documents/fs/0068.pdf</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>5186</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>74768</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>24850</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827948</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>23233</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Aluminium_sulfate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL3833402</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>